U.S. Biotech Stock News

Lear Corporation is set to report its December 2025 quarter results on February 4, with analysts expecting lower earnings year over year on higher revenues and a positive Earnings ESP of 1.75% versus the Zacks Consensus Estimate. The gap between the Most Accurate Estimate and the broader consensus highlights a recent shift in analyst expectations that could influence how investors interpret Lear’s upcoming earnings quality. We’ll now explore how the bullish shift in earnings estimates shapes...

Recent coverage shows that Weis Markets’ return on capital employed (ROCE) has fallen over the past five years to about 7.2%, now trailing the wider Consumer Retailing industry average of roughly 12%. This downward ROCE trend, alongside largely unchanged capital employed, points to a mature business model that may offer fewer avenues for reinvesting capital at higher returns. We’ll now examine how this weaker ROCE profile shapes Weis Markets’ investment narrative and what it might mean for...

U.S. Bancorp (USB) has drawn fresh attention after earnings estimate revisions, recent outperformance relative to its industry, and a cluster of leadership changes that include board succession and planned executive retirements. See our latest analysis for U.S. Bancorp. At a share price of US$56.11, U.S. Bancorp has seen momentum build over the past quarter, with a 90 day share price return of 20.85% and a 1 year total shareholder return of 25.00%, as investors react to earnings, buybacks and...

Zimmer Biomet has recently drawn attention for its HipInsight™ System, which brings augmented reality into orthopedic surgery to provide surgeons with real-time visual guidance during hip replacement procedures. This focus on digitally integrated, robotic-assisted solutions positions the company at the center of a rapidly evolving hip replacement market shaped by demographic trends and technological innovation. With this context, we will now explore how Zimmer Biomet’s push into augmented...

F5, Inc. recently reported first-quarter fiscal 2026 results showing revenue of US$822.47 million and higher earnings than a year earlier, and raised its full-year revenue growth guidance to a 5%–6% range. Management linked the stronger outlook to sustained demand for its application security and multicloud products, even as the company continues to manage the fallout from a previously disclosed nation-state cyber breach and related legal actions. We’ll now examine how the upgraded full-year...

Applied Industrial Technologies reported second-quarter 2026 results showing higher sales of US$1,163.02 million and modest earnings growth, while also raising full-year earnings and sales guidance. The company coupled this outlook upgrade with an 11% dividend increase and plans for more acquisitions in automation, fluid power, and flow control, highlighting a continued emphasis on engineered solutions. With the company eyeing more M&A to expand its engineered solutions footprint, we'll...

Cincinnati Financial (CINF) has increased its regular quarterly cash dividend by 8% to $0.94 per share. The dividend is scheduled to be paid on April 15, 2026, to shareholders of record as of March 24. See our latest analysis for Cincinnati Financial. The dividend increase comes as Cincinnati Financial’s 1 year total shareholder return of 20.21% and 5 year total shareholder return of 107.68% outpace its recent 30 day share price return. This suggests that longer term momentum has been...

In late January 2026, United Rentals reported fourth-quarter and full-year 2025 results showing higher revenue but lower net income year over year, alongside a 10% increase in its quarterly dividend to US$1.97 per share and new full-year 2026 revenue guidance of US$16.8 billion to US$17.3 billion. At the same time, the company paired a new US$5 billion share repurchase authorization with ongoing margin pressures and earnings that fell short of analyst expectations, creating a mixed picture...

SL Green Realty Corp. reported full-year 2025 results showing revenue of US$1.00 billion and sales of US$601.54 million, but moved from net income of US$30.65 million in 2024 to a net loss of US$230.93 million and shifted its ordinary dividend payments from monthly to quarterly starting in 2026. Despite the loss, the company closed 2.6 million square feet of Manhattan office leasing in 2025, lifted same-store occupancy to 93%, and outlined a US$7 billion refinancing and US$2.50 billion asset...

F.N.B. Corporation recently reported fourth-quarter 2025 results showing higher net interest income and net income than a year earlier, while its Board declared a US$0.12 per-share quarterly common dividend payable on March 16, 2026, to shareholders of record on March 2, 2026. The company also completed a multi-year share repurchase effort, buying back 17,699,839 shares for US$214.08 million since 2019, highlighting a sustained focus on returning capital to shareholders. Against this...

Arcos Dorados Holdings (NYSE:ARCO) is drawing fresh attention after outlining plans to open 105 to 115 new restaurants across Latin America and the Caribbean in 2026, funded mainly through operating cash flow and existing reserves. See our latest analysis for Arcos Dorados Holdings. The expansion plan and recent cash tender offer for up to US$150 million of sustainability linked notes have coincided with firming momentum, with a 30 day share price return of 12.21% and a 1 year total...

Kinsale Capital Group recently reported strong past growth in net premiums earned and a sharp acceleration in book value per share, underscoring robust demand for its specialty insurance offerings. This combination of expanding premiums and rapidly rising book value per share highlights how effectively Kinsale is converting underwriting activity into shareholder equity. We’ll now explore how Kinsale’s accelerating book value per share growth shapes the company’s broader investment narrative...

Allegro MicroSystems (ALGM) drew investor attention after its latest quarterly report, with sales outpacing expectations, earnings turning positive, and management flagging continued strength in automotive, e-Mobility and data center focused industrial demand. See our latest analysis for Allegro MicroSystems. The earnings beat and upbeat guidance have been reflected in the share price, with a 30 day share price return of 37.16% and a 90 day gain of 34.51% from a latest close of US$36.91. Over...

In January 2026, Quantexa announced that its Decision Intelligence Accelerator for Guidewire ClaimCenter became globally available on the Guidewire Marketplace, integrating real-time fraud detection, claims segmentation, and contextual analytics into Guidewire Cloud workflows. This move deepens Guidewire’s role at the center of the insurance technology ecosystem by embedding partner-powered decision intelligence directly where claims decisions are made. Against this backdrop, we’ll examine...

Nicolet Bankshares, Inc. recently reported fourth-quarter and full-year 2025 results showing higher net interest income and net income than a year earlier, and shareholders in January 2026 approved an amendment to increase the company’s authorized share count. Alongside earnings growth, Nicolet completed a long-running share repurchase program, modestly increased net loan charge-offs, and affirmed a US$0.32 quarterly dividend payable in March 2026. We’ll now examine how Nicolet’s stronger...

While Columbia Sportswear Company ( NASDAQ:COLM ) might not have the largest market cap around , it saw a decent share...

To the annoyance of some shareholders, SS Innovations International, Inc. ( NASDAQ:SSII ) shares are down a...

It's not a stretch to say that QuinStreet, Inc.'s ( NASDAQ:QNST ) price-to-sales (or "P/S") ratio of 0.7x right now...

To the annoyance of some shareholders, Similarweb Ltd. ( NYSE:SMWB ) shares are down a considerable 27% in the last...

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...

Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Anyone who held...

In recent days, AbbVie has highlighted its shift away from Humira toward newer immunology drugs such as Skyrizi and Rinvoq, while progressing a broad pipeline that includes treatments for Parkinson’s disease and aggressive blood cancers, following mixed but generally constructive clinical and policy updates across its portfolio. An interesting angle for investors is how AbbVie’s push into next‑generation immunology and aesthetics, alongside its long dividend‑increase record, is reshaping...

What recent performance tells you about Impinj (PI) Impinj (PI) has drawn attention after a month return of about 23% decline and a past 3 months return of about 21% decline, despite a 1 year total return above 12%. See our latest analysis for Impinj. With the share price at about $138.10 after a 7 day share price return of around a 15% decline and a 30 day share price return of about a 23% decline, the recent pullback contrasts with a 1 year total shareholder return of roughly 13%. This...

Goldman Sachs endorsement puts Golar LNG in focus Goldman Sachs recently added Golar LNG (GLNG) to its US Conviction List, citing expectations for the company’s contracted EBITDA to triple by 2028 as new liquefaction capacity comes online. This endorsement from a major investment bank draws attention to Golar LNG’s role in floating LNG infrastructure. It also raises fresh questions for investors around contract visibility, future cash generation, and how today’s share price reflects those...